Ken Griffin acquired 34.6 Thousand Terns Pharmaceuticals shares worth $162 Thousand. That's 0.00% of their equity portfolio (4206th largest holding). The first Terns Pharmaceuticals trade was made in Q1 2021. Since then Ken Griffin bought shares three more times and sold shares on six occasions. The investor's estimated purchase price is $229 Thousand, resulting in a loss of 29%.